QUICKI — Quantitative Insulin Sensitivity Check Index
QUICKI (Quantitative Insulin Sensitivity Check Index) is a simple, validated index for assessing insulin sensitivity derived from fasting glucose and insulin concentrations.
About
QUICKI was developed by Katz et al. in 2000 as an alternative to the hyperinsulinemic-euglycemic clamp, the gold standard for measuring insulin sensitivity. Unlike the clamp technique, which is labor-intensive, invasive, and impractical for clinical use, QUICKI provides a rapid assessment from a single fasting blood sample. It is calculated as the reciprocal of the sum of log-transformed fasting insulin and fasting glucose concentrations: QUICKI = 1 / (log(I₀) + log(G₀)), where I₀ is fasting insulin in μU/mL and G₀ is fasting glucose in mg/dL. QUICKI correlates well with clamp-derived insulin sensitivity (r = 0.7-0.9) and has been validated across diverse populations including normal, obese, diabetic, and polycystic ovary syndrome patients. Values >0.45 indicate normal insulin sensitivity, 0.35-0.45 indicate reduced insulin sensitivity, and <0.35 indicate severe insulin resistance. QUICKI is particularly useful for epidemiological studies and clinical research where clamp techniques are not feasible, and for monitoring changes in insulin sensitivity over time in response to interventions (weight loss, exercise, medications).
Formula
QUICKI = 1 / (log₁₀(fastingInsulin) + log₁₀(fastingGlucose))
QUICKI is calculated from fasting insulin (μU/mL) and fasting glucose (mg/dL) using the formula above. Both values are log-transformed before summation. The result is a numeric value typically ranging from 0.25 to 0.55, with higher values indicating better insulin sensitivity. QUICKI can be used with either log₁₀ or natural log (ln) — the result is the same either way. The index has been validated against the gold-standard hyperinsulinemic-euglycemic clamp, demonstrating strong correlation particularly in non-diabetic individuals.
Score Interpretation
QUICKI provides a practical, non-invasive estimate of insulin sensitivity suitable for clinical and research settings. It is particularly valuable for longitudinal monitoring of insulin sensitivity changes in response to interventions such as weight loss, exercise programs, and insulin-sensitizing medications. While QUICKI correlates well with clamp studies in population-level analyses, it has limited precision for individual-level diagnosis of insulin resistance, and its primary utility is in epidemiological research and clinical trials rather than routine individual patient management.
Normal Insulin Sensitivity — 0.46+
QUICKI >0.45. Normal insulin sensitivity.
Management: Continue healthy lifestyle. Routine monitoring.
Reduced Insulin Sensitivity — 0.35–0.45
QUICKI 0.35-0.45. Reduced insulin sensitivity. Increased metabolic risk.
Management: Lifestyle modification. Screen for metabolic syndrome. Consider HbA1c and OGTT.
Severe Insulin Resistance — 0–0.34
QUICKI <0.35. Severe insulin resistance. Strongly associated with diabetes.
Management: Urgent evaluation for type 2 diabetes. Aggressive lifestyle and pharmacotherapy. Endocrinology referral.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Healthy adults with normal glucose tolerance | >0.45 | Values vary with age, sex, and ethnicity |
Dr. Khaled Hassan
Dr. Khaled is a cardiology consultant with experience in acute cardiac care.
View medical review board & editorial policy →Example Calculation
A 45-year-old woman with PCOS and BMI 32 kg/m² undergoes metabolic screening: fasting glucose 98 mg/dL, fasting insulin 18 μU/mL. QUICKI = 1 / (log₁₀(18) + log₁₀(98)) = 1 / (1.255 + 1.991) = 1 / 3.246 = 0.308. Interpretation: QUICKI <0.35 indicates severe insulin resistance. She is diagnosed with metabolic syndrome and started on metformin 500 mg twice daily with lifestyle counseling.
Related Conditions
Related Medications
Common Mistakes
Using random (non-fasting) glucose and insulin values
QUICKI requires fasting glucose and insulin (≥8 hours fasting). Postprandial values will give falsely abnormal results as insulin rises significantly after meals.
Interpreting QUICKI as a diagnostic test for diabetes
QUICKI assesses insulin sensitivity, not glucose tolerance. It cannot diagnose diabetes or prediabetes. Use HbA1c, fasting glucose, or OGTT for diabetes diagnosis.
Frequently Asked Questions
How does QUICKI compare to HOMA-IR?
Can QUICKI be used in patients on insulin therapy?
References
- Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402-2410. PubMed
- Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes. 2005;54(7):1914-1925. PubMed